Abbott Laboratories (ABT) – Bull of the Day
Source: http://www.zacks.com/commentary/9830/Abbott+Laboratories+%28ABT%29+-+Bull+of+the+DayPosted on Thursday, January 22nd, 2009 | In Stocks to Watch
Contributed by: Zacks Market Commentaries (http://www.zacks.com/) -
Abbott Laboratories (ABT) discovers, develops, manufactures and sells a diversified line of healthcare products. We expect high-single digit EPS growth over the next five years driven by strong sales of Humira and the company’s rapidly growing vascular business.
Several new drug applications have recently been filed with the FDA which should accelerate sales in the pharmaceutical business. We believe ABT possesses a low risk profile and will continue to trade at an industry premium.
Accordingly, we reiterate our Buy recommendation with a price target of $65.
“ABT” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- CNP & FPL Ink Pipeline Deal - Analyst Blog - November 20th, 2009
- Buffett Borrows for Rail Acquisition - Analyst Blog - November 20th, 2009
- Stone Energy Outdoes Estimates - Analyst Blog - November 20th, 2009
- Smucker's Beats, Raises Guidance - Analyst Blog - November 20th, 2009
- GameStop Meets Expectations - Analyst Blog - November 20th, 2009
Tags for this Post:
Abbott Laboratories, Day Abbott Laboratories;, Fda, healthcare products, Humira, Pharmaceutical, Stocks to Watch, USD, Zacks Market Commentaries
Abbott Laboratories, Day Abbott Laboratories;, Fda, healthcare products, Humira, Pharmaceutical, Stocks to Watch, USD, Zacks Market Commentaries
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.